Incidence
The prevalence of meningitis cases notified to public health from 1991-2003 in England and Wales, stratified by microbiological aetiology, is shown in Fig 1. Most reported cases are bacterial (Fig 2) , the most common pathogens now being Neisseria meningitidis and Streptococcus pneumoniae, 3 although aetiology varies with age. Cases due to Gram-negative organisms such as Escherichia coli and Klebsiella spp 1 have increased over the last four decades, reflecting nosocomial infections through advancing neurosurgical and oncological procedures.
The impact of vaccines

Significant recent advances have been the introduction of vaccines against
Haemophilus influenzae type B (Hib) and N. meningitidis serogroup C. Routine immunisation with these vaccines began in the UK in 1992 and 1999, respectively, with impressive reductions of disease (Fig 3) . There is currently no vaccine for N. meningitidis serogroup B, now responsible for most meningococcal disease in the UK. In the USA, the incidence of invasive pneumococcal disease has fallen significantly since the deployment of the 7-valent conjugate pneumococcal vaccine introduced in 2001.
Each modern conjugate vaccine targets capsular polysaccharides and reduces nasopharyngeal colonisation by bacteria expressing the cognate capsular antigen. The concern that this might lead to 'serotype replacement' , in which disease caused by bacteria with hitherto uncommon capsule types emerges, has not been substantiated.
The availability of vaccine varies widely worldwide and bacterial meningitis is still a major cause of mortality and morbidity in poorer countries. For example, in the World Health Organization African region H. influenzae causes an estimated 100,000-160,000 child deaths each year. S. pneumoniae causes 250,000-400,000 child deaths per year and N. meningitidis is responsible for large epidemics (causing thousands of deaths) in many West and Central African countries. 4 (Tables 1  and 2 ).
Clinical features
Diagnosis
All patients with suspected meningitis should undergo lumbar puncture (LP) to obtain cerebrospinal fluid (CSF) for laboratory analysis. Classic CSF results are summarised in Table 3 . Contraindications to LP include raised intracerebral pressure (Fig 4) , local topical infection and bleeding diatheses. Cranial computed tomography (CT) prior to LP is not necessary routinely unless there are:
• 
Management of bacterial meningitis
The administration of parenteral antibiotics (usually benzylpenicillin) in the community is standard practice for suspected meningitis in the UK. 7 In penicillin allergy, the risk/benefit of an anaphylaxis history (absolute contraindication), the degree of diagnostic suspicion and rapidity of access to secondary care should be considered. Cefotaxime or chloramphenicol are acceptable alternatives (Table 5) . 8 In hospital, delivery of empiric parenteral antibiotics should not be delayed for clinical investigation such as CT of the head or lumbar puncture, as delay can significantly increase mortality and morbidity. 9, 10 Cefotaxime is the empiric antibiotic of choice for most patients (Tables 6 and 7) . 11, 12 Modification case-by-case could include adding vancomycin if there is concern about penicillin-resistant pneumococci or Staphylococcus aureus, or high-dose ampicillin if listeriosis is suspected, particularly in neonates, the elderly and the immunosuppressed. 13 
Use of steroids
The routine use of steroids in the management of bacterial meningitis in children 14 has declined over the last decade following Hib vaccine introduction, with some evidence from the tropics of adverse effects. 15 Considerable controversy also exists over the benefit of steroids in adults. A recent multicentre randomised controlled trial revealed moderate benefit for patients with all causes of bacterial meningitis, but subgroup analysis of patients with pneumococcal disease revealed a significant reduction in adverse outcome. 16 Therefore, current advice is that steroid use is justified if there is a strong suspicion of pneumococcal disease. 11 
Chemoprophylaxis for contacts
Local public health departments should be notified of all cases of meningitis; they will coordinate administration of prophylaxis to household contacts of 
Management of tuberculous meningitis
Symptom onset in tuberculous meningitis is often insidious, with headache, lethargy, fever, weight loss and night sweats. Many patients will have evidence of tuberculosis (TB) elsewhere, often with an abnormal chest radiograph. Laboratory confirmation can be difficult as the yield of Mycobacterium tuberculosis from CSF is low. If clinical suspicion is high, treatment should be initiated without waiting for further laboratory results as untreated tuberculous meningitis carries a 100% mortality. Samples of CSF should be sent for prolonged culture for TB, as should sputum (obtained by induction with hypertonic saline if necessary) and early morning urine samples.
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Unless there is a high suspicion of multidrug resistant TB (MDRTB), 12 months of standard TB therapy is appropriate, 18 with doses calculated by weight (Table 8) . Paradoxically, tuberculous lesions can expand in early treatment and tuberculous meningitis is associated with cerebral microabscesses, therefore steroids should be prescribed at the initiation of therapy. As with all TB, there is an increased incidence of coinfection with HIV and patients should be counselled and tested accordingly. Expert advice should be sought for management of MDRTB. 
Management of viral meningitis
Meningitis in the immunocompromised host
Bacteria are the most common cause of meningitis in immunocompromised patients, particularly pneumococcal disease in Africa, and Listeria monocytogenes in the immunosuppressed. Meningitis due to Cryptococcus neoformans has increased in incidence since the onset of the AIDS pandemic, but was well recognised previously in both immunocompetent people and those compromised by lymphoreticular malignancies and transplants (both solid organ and bone marrow). Treatment is with flucytosine and amphotericin B. Expert specialist opinion should be sought at the earliest opportunity.
Human immunodeficiency virus (HIV) alone can cause viral meningitis, most commonly as part of a seroconversion illness. Advancing HIV disease leads to increased risk of many infections, including meningitis due to TB, cytomegalovirus and toxoplasma as well as C. neoformans. Timely involvement of physicians trained in HIV medicine is vital.
Future trends
Further development and deployment of effective vaccines, including novel meningococcal and pneumococcal vaccines, will be required to reduce the burden of bacterial meningitis. The most urgent need is for a vaccine against serogroup B meningococcus. Immuno The public usually expects to be immunised against infections such as typhoid and hepatitis A before travelling to more exotic destinations but are largely unaware that avoiding the more significant threats to health and life depends more on their behaviour abroad and on prompt presentation to informed doctors should they become ill on return.
What is special about returned travellers?
Returned travellers most commonly present with fever, skin lesions, diarrhoea, jaundice or anxiety that they may be incubating an infection. Febrile patients require the most urgent assessment.
Being confronted with a patient recently returned from overseas can be a daunting experience for doctors concerned that they may miss unfamiliar but urgent life-threatening conditions. Although returned travellers present with a variety of symptoms, the possibility of a fatal outcome is virtually confined to those with fever. A safe management protocol for such patients is identical to what should be followed in managing any acutely febrile patient, with the important addition, when appropriate, of urgent investigation for falciparum malaria coupled with preparedness to treat for malaria even when a negative result is obtained. Timing is of the essence: treated early, malaria is simple to cure but delays of only a few days can allow progression to severe disease with full-blown sepsis necessitating intensive care.
The standard protocol for febrile patients (see below) includes a chest X-ray; this usually shows non-lobar consolidation in patients with legionellosis, often when pneumonia would not have been thought likely from the patient's symptoms. Approximately half of notified Legionnaires' disease in the UK occurs in returned travellers and the infection kills as many such individuals each year as falciparum malaria.
